2.3.1.122 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=24455775&form=6&db=m Administration of mycobacterial Ag85A and IL-17A fusion protein attenuates airway inflammation in a murine model of asthma. causal interaction,ongoing research,therapeutic application,unassigned 2,4,1,0 2.3.1.122 Asthma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=29302700&form=6&db=m Immunization with an adenovirus-vectored TB vaccine containing Ag85A-Mtb32 effectively alleviates allergic asthma. ongoing research,therapeutic application,unassigned 4,2,0 2.3.1.122 Buruli Ulcer http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=11500410&form=6&db=m Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer. therapeutic application,unassigned 2,0 2.3.1.122 Buruli Ulcer http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26393347&form=6&db=m Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer. ongoing research,therapeutic application,unassigned 2,3,0 2.3.1.122 Buruli Ulcer http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30090691&form=6&db=m IFN-? and IL-5 whole blood response directed against mycolactone polyketide synthase domains in patients with Mycobacterium ulcerans infection. diagnostic usage,ongoing research,therapeutic application,unassigned 2,1,2,0 2.3.1.122 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26238268&form=6&db=m Enhanced therapeutic effects against murine colon carcinoma induced by a Colon 26/Ag85A-CD226 tumor cell vaccine. causal interaction,ongoing research,therapeutic application,unassigned 3,4,4,0 2.3.1.122 Carcinoma http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30542467&form=6&db=m Dendritic cell vaccine with Ag85A enhances anti-colorectal carcinoma immunity. unassigned - 2.3.1.122 Coinfection http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=23369570&form=6&db=m A novel DNA vaccine expressing the Ag85A-HA2 fusion protein provides protection against influenza A virus and Staphylococcus aureus. ongoing research,therapeutic application,unassigned 1,1,0 2.3.1.122 Extensively Drug-Resistant Tuberculosis http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=33333421&form=6&db=m Identification of potent Antigen 85C inhibitors of Mycobacterium tuberculosis via in-house lichen library and binding free energy studies Part-II. causal interaction,therapeutic application,unassigned 3,3,0 2.3.1.122 Fowlpox http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=15196215&form=6&db=m Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin. ongoing research,therapeutic application,unassigned 2,1,0